1. Arai, E., M. Shimizu, and T. Hirose, A review of 55 cases of cutaneous lymphoid hyperplasia: reassessment of the histopathologic findings leading to reclassification of 4 lesions as cutaneous marginal zone lymphoma and 19 as pseudolymphomatous follikulitis. Human Pathology, 2005. 36(5): p. 505-511.
2. Bailey, E.M., et al., Marginal Zone Lymphoma (Low-grade B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Type) of Skin and Subcutaneous Tissue. The American Journal of Surgical Pathology, 1996. 20(8): p. 1011-1023.
3. Baldassano, M.F., et al., Cutaneous Lymphoid Hyperplasia and Cutaneous Marginal Zone Lymphoma. The American Journal of Surgical Pathology, 1999. 23(1): p. 88-96.
4. Cerroni, L., et al., Primary Cutaneous Marginal Zone B-Cell Lymphoma: A Recently Described Entity of Low-Grade Malignant Cutaneous B-Cell Lymphoma. The American Journal of Surgical Pathology, 1997. 21(11): p. 1307-1315.
5. Deutsch, A.J.A., et al., Primary Cutaneous Marginal Zone B-Cell Lymphomas Are Targeted by Aberrant Somatic Hypermutation. Journal of Investigative Dermatology, 2009. 129(2): p. 476-479.
6. Goldberg, L.J., Cicatricial marginal alopecia: is it all traction? British Journal of Dermatology, 2009. 160(1): p. 62-68.
7. Lan, T.T., N.A. Brown, and A.C. Hristov, Controversies and considerations in the diagnosis of primary cutaneous CD4(+) small/medium T-cell lymphoma. Arch Pathol Lab Med, 2014. 138(10): p. 1307-18.
8. van Maldegem, F., et al., The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment. Blood, 2008. 112(8): p. 3355-3361.
9. Willemze, R., et al., Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2013. 24 Suppl 6: p. vi149-54.
10. Stadler, R., et al., Short German guidelines: cutaneous lymphomas. J Dtsch Dermatol Ges, 2008. 6 Suppl 1: p. S25-31.
